Literature DB >> 14701841

Structural characterization of TSC-36/Flik: analysis of two charge isoforms.

Harald O Hambrock1, Brigitte Kaufmann, Stefan Müller, Franz-Georg Hanisch, Kiyoshi Nose, Mats Paulsson, Patrik Maurer, Ursula Hartmann.   

Abstract

Recombinant forms of the glycoprotein TSC-36/Flik were expressed in human cells and used to compare their structural and functional properties with those described for other members of the BM-40/SPARC/osteonectin protein family. TSC-36 was found to occur in two charge isoforms that differ in the extent of sialylation of otherwise identical N-linked, complex type oligosaccharides. Conformational analysis with both circular dichroism and intrinsic fluorescence spectroscopy showed a lack of significant structural changes upon calcium addition or depletion. This finding is in contrast to results obtained for several other BM-40 family members and indicates that the extracellular calcium-binding domain in TSC-36 is non-functional. The lack of conservation of important functional features common to several other members of the BM-40 family indicates that TSC-36, despite its sequence homology to BM-40, has evolved clearly distinct properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701841     DOI: 10.1074/jbc.M309318200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression.

Authors:  Yury Chaly; Anthony D Marinov; Leif Oxburgh; Daniel S Bushnell; Raphael Hirsch
Journal:  Arthritis Rheum       Date:  2011-10-17

2.  Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium.

Authors:  Tomohiro Umezu; Hiromi Yamanouchi; Yusuke Iida; Masataka Miura; Yasuhiro Tomooka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

3.  DIP2A functions as a FSTL1 receptor.

Authors:  Noriyuki Ouchi; Yasuhide Asaumi; Koji Ohashi; Akiko Higuchi; Saki Sono-Romanelli; Yuichi Oshima; Kenneth Walsh
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

4.  Structural and functional study of FK domain of Fstl1.

Authors:  Xinxin Li; Lian Li; Yue Chang; Wen Ning; Xinqi Liu
Journal:  Protein Sci       Date:  2019-08-09       Impact factor: 6.725

5.  Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.

Authors:  Yan Geng; Yingying Dong; Mingyan Yu; Long Zhang; Xiaohua Yan; Jingxia Sun; Long Qiao; Huixia Geng; Masahiro Nakajima; Tatsuya Furuichi; Shiro Ikegawa; Xiang Gao; Ye-Guang Chen; Dianhua Jiang; Wen Ning
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 6.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

7.  Follistatin-like 1 regulates renal IL-1β expression in cisplatin nephrotoxicity.

Authors:  Derek C Adams; Michele J Karolak; Barry W Larman; Lucy Liaw; James D Nolin; Leif Oxburgh
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

8.  The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.

Authors:  Jean-Francois Mouillet; Takuya Mishima; Andrea Mollica do Amarante Paffaro; Tony W Parks; Judy A Ziegler; Tianjiao Chu; Yoel Sadovsky
Journal:  Placenta       Date:  2015-09-10       Impact factor: 3.481

Review 9.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

10.  Differential expression patterns of occ1-related genes in adult monkey visual cortex.

Authors:  Toru Takahata; Yusuke Komatsu; Akiya Watakabe; Tsutomu Hashikawa; Shiro Tochitani; Tetsuo Yamamori
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.